Evidence map›Paper›PMID 35328562›Full record

ArticleInternational journal of molecular sciences2022

An Upgrade on the Surveillance System of SARS-CoV-2: Deployment of New Methods for Genetic Inspection.

José Francisco Muñoz-Valle, Alberto Antony Venancio-Landeros, Rocío Sánchez-Sánchez, Karen Reyes-Díaz, Byron Galindo-Ornelas, Wendy Susana Hérnandez-Monjaraz, Alejandra García-Ríos, Luis Fernando García-Ortega, Jorge Hernández-Bello, Marcela Peña-Rodríguez and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

José Francisco Muñoz-ValleInstitute for Research in Biomedical Sciences (IICB), University Center for Health Sciences, University of Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0002-2272-9260
Alberto Antony Venancio-LanderosTranslational Institute of Genomic Singularity (ITRASIG), Irapuato 36615, Mexico.ORCID 0000-0003-0377-2762
Rocío Sánchez-SánchezMolecular Design Department, Genes2Life (Grupo T), Irapuato 36615, Mexico.
Karen Reyes-DíazResearch and Development Department, Genes2Life (Grupo T), Irapuato 36615, Mexico.
Byron Galindo-OrnelasResearch and Development Department, Genes2Life (Grupo T), Irapuato 36615, Mexico.ORCID 0000-0003-4605-9537
Wendy Susana Hérnandez-MonjarazResearch and Development Department, Genes2Life (Grupo T), Irapuato 36615, Mexico.
Alejandra García-RíosResearch and Development Department, Genes2Life (Grupo T), Irapuato 36615, Mexico.
Luis Fernando García-OrtegaDepartment of Genetic Engineering, Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Irapuato 36824, Mexico.
Jorge Hernández-BelloInstitute for Research in Biomedical Sciences (IICB), University Center for Health Sciences, University of Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0001-8004-1811
Marcela Peña-RodríguezLaboratory for the Diagnosis of Emerging and Reemerging Diseases (LaDEER), University Center for Health Sciences, University of Guadalajara, Guadalajara 44340, Mexico.
Natali Vega-MagañaInstitute for Research in Biomedical Sciences (IICB), University Center for Health Sciences, University of Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0003-4749-2498
Luis DelayeDepartment of Genetic Engineering, Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Irapuato 36824, Mexico.ORCID 0000-0003-4193-2720
Mauricio Díaz-SánchezResearch and Development Department, Genes2Life (Grupo T), Irapuato 36615, Mexico.ORCID 0000-0001-7006-899X
Octavio Patricio García-GonzálezTranslational Institute of Genomic Singularity (ITRASIG), Irapuato 36615, Mexico.
Universidad de Guadalajara · MXCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXInstituto Tecnológico Superior de Irapuato · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 variants surveillance is a worldwide task that has been approached with techniques such as Next Generation Sequencing (NGS); however, this technology is not widely available in developing countries because of the lack of equipment and limited funding in science. An option is to deploy a RT-qPCR screening test which aids in the analysis of a higher number of samples, in a shorter time and at a lower cost. In this study, variants present in samples positive for SARS-CoV-2 were identified with a RT-qPCR mutation screening kit and were later confirmed by NGS. A sample with an abnormal result was found with the screening test, suggesting the simultaneous presence of two viral populations with different mutations. The DRAGEN Lineage analysis identified the Delta variant, but there was no information about the other three mutations previously detected. When the sequenced data was deeply analyzed, there were reads with differential mutation patterns, that could be identified and classified in terms of relative abundance, whereas only the dominant population was reported by DRAGEN software. Since most of the software developed to analyze SARS-CoV-2 sequences was aimed at obtaining the consensus sequence quickly, the information about viral populations within a sample is scarce. Here, we present a faster and deeper SARS-CoV-2 surveillance method, from RT-qPCR screening to NGS analysis.

Indexed as

MutationCOVID-19DNA Mutational AnalysisGenome, ViralHigh-Throughput Nucleotide SequencingHumansPandemicsReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2Sensitivity and Specificitygenetic surveillanceqPCR variant screeningSARS-CoV-2 epidemiologySARS-CoV-2 variant identification

Identifiers

PMID35328562
PMCPMC8950365
OpenAlexW4220807607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.